Macro Group Pharmaceuticals (Macro Capital) S.A.E
Macro Group Pharmaceuticals (Macro Capital) S.A.E., headquartered in Egypt, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of innovative healthcare solutions. Founded in 2016, the company has rapidly established itself as a leader in the production of high-quality injectable and topical pharmaceuticals, catering to both local and international markets. With a strong focus on research and development, Macro Group Pharmaceuticals offers a diverse portfolio of products, including advanced formulations that address various medical needs. The company is recognised for its commitment to quality and safety, ensuring that its offerings meet stringent regulatory standards. As a result, Macro Group has achieved significant market presence and is well-regarded for its contributions to the healthcare sector in Egypt and beyond.
DitchCarbon Score
How does Macro Group Pharmaceuticals (Macro Capital) S.A.E's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Macro Group Pharmaceuticals (Macro Capital) S.A.E's score of 10 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Macro Group Pharmaceuticals (Macro Capital) S.A.E's reported carbon emissions
Macro Group Pharmaceuticals (Macro Capital) S.A.E, headquartered in Egypt, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Macro Group Pharmaceuticals has not established any significant climate commitments or initiatives aimed at reducing its carbon footprint. The lack of emissions data and reduction strategies suggests that the company may still be in the early stages of developing a comprehensive climate action plan. In the context of the pharmaceutical industry, it is increasingly important for companies to adopt sustainable practices and set measurable targets to mitigate climate impact. Without specific emissions data or commitments, Macro Group Pharmaceuticals may face challenges in aligning with industry standards and expectations regarding environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Macro Group Pharmaceuticals (Macro Capital) S.A.E is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
